Cough Medicine Ingredient Could Treat Prostate Cancer, Study Shows
By Wednesday, 31 December 2008 00:00
A laboratory study published December 18 in the December issue of the European medical journal Anticancer Research reports that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, in mice reduced tumor growth by 60% and limited the spread of tumors by 65% without causing harmful side effects.
Noscapine is approved for use in some countries as a cough suppressant or available as an over the counter cough medicine, and Dr. Barken has prescribed it "off-label" to patients with prostate cancer.
However, patients who have taken noscapine in an effort to control prostate cancer do not appear to have benefited so far.
Read more: Cough Medicine Ingredient Could Treat Prostate Cancer, Study Shows
Dentist Links Fosamax-type Drugs to Jaw Necrosis
By Thursday, 01 January 2009 12:00
Researchers at the University Of Southern California, School Of Dentistry have released results of clinical data that links oral bisphosphonates to increased jaw necrosis. Their study, published today in January 1 Journal of the American Dental Association (JADA), is among the first to acknowledge that even short-term use of common oral osteoporosis drugs such as Fosamax may leave the jaw vulnerable to devastating necrosis.
If anything, TV commercials like the one for Boniva featuring Sally Field ("I've got this one body") have tended to glamorize this class of drugs.
Friday, 02 January 2009 00:00
Seeding for Prostate Cancer Not Affected by Adverse Family History
Having a father or brother with prostate cancer has no impact on the outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), according to a January 1 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology. Patients with a first-degree family history have clinical and pathologic characteristics similar to men with no family history at all.
Why Androgen Blockade Therapy Stops Working for Prostate Cancer Patients
Wednesday, 31 December 2008 00:05
Androgen blockade therapy for men with advanced prostate cancer often yields only a temporary fix or respite, not a permanent cure. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. The findings, reported in the Jan. 1 issue of Cancer Research, could lead to a way to track disease progression, as well as new targets to fight prostate cancer.Low-Income Men More Likely to be Diagnosed with Advanced Prostate Cancers
Wednesday, 17 December 2008 00:00
Low-income men are more likely to present with advanced prostate cancers, most likely because they don’t receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.The study focused on a group of disadvantaged men enrolled in the state’s IMPACT (Improving Access, Counseling and Treatment for Californians with Prostate Cancer) program, which provides high-quality care to poor, underinsured and uninsured men. Researchers found that of the 570 men studied, 19 percent had metastatic cancer at diagnosis, compared to 4 percent of men from the general population who were followed in other studies.
Read more: Low-Income Men More Likely to be Diagnosed with Advanced Prostate Cancers
More Articles...
Page 7 of 9
